홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

티니다졸

Tinidazole

HCID 5479
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
148159-84-6
표준 SMILES
CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C
InChIKey
HJLSLZFTEKNLFI-UHFFFAOYSA-N
분자식
C8H13N3O4S
평균 분자량
247.27 g/mol
단동위원소 질량
247.0626769

개요

Tinidazole is 1H-imidazole substituted at C-1 by a (2-ethylsulfonyl)ethyl group, at C-2 by a methyl group and at C-5 by a nitro group. It is used as an antiprotozoal, antibacterial agent. It has a role as an antiamoebic agent, an antiparasitic agent, an antiprotozoal drug and an antibacterial drug.

이름 및 식별자

우선 이름
Tinidazole
IUPAC
1-(2-ethylsulfonylethyl)-2-methyl-5-nitroimidazole
현지명
티니다졸
영어명
Tinidazole
분자식
C8H13N3O4S
분자량
247.27

이름 및 동의어

tinidazole19387-91-8FasigynTrimonaseFasiginTricolam1-(2-(Ethylsulfonyl)ethyl)-2-methyl-5-nitro-1H-imidazoleSimplotanTinidazolSorquetanHaisigynTinidazolum
이름 더 보기
1-[2-(에틸설포닐)에틸]-2-메틸-5-니트로-1H-이미다조드티니다졸,페시진티니다졸TIXIAOZUO1-(2-(ethylsulfonyl)ethyl)-2-methyl-5-nitro-1h-imidazolpletibioshikcp12574
1-(2-ethylsulfonylethyl)-2-methyl-5-nitroimidazolePletilCP 12574timidazole1-[2-(Ethylsulfonyl)ethyl]-2-methyl-5-nitro-1H-imidazoleCP-125741-[2-(ethanesulfonyl)ethyl]-2-methyl-5-nitro-1H-imidazoleDTXSID4023676

데이터베이스 식별자

CAS
148159-84-6、19387-91-8
PubChem CID
5479
DTXSID
DTXSID4023676
ChEMBL
CHEMBL1220
ChEBI
CHEBI:63627
UNII
033KF7V46H
EC Number
243-014-4
Nikkaji
J2.752I

물성

구조 계산 물성

XLogP
-0.4
극성 표면적
106 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
5
회전 가능 결합 수
4
무거운 원자 수
16
형식 전하
0
복잡도
345

실험 및 물리화학적 성질

Drugs · 2건

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Antibiotics

LogP · 3건

log Kow = -0.35

0.7

-0.38

Color/FormColorless crystals from benzene
Solubility · 2건

3.03e+00 g/L

>37.1 [ug/mL] (The mean of the results at pH 7.4)

Human Drugs · 4건

Breast Feeding; Lactation; Anti-Infective Agents; Antibacterial Agents; Antiprotozoal Agents; Nitroimidazoles

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Antiamoebic and antigiardiasis medicines

Animal DrugsPharmaceuticals -> Animal Drugs -> Approved in Taiwan
Melting Point · 3건

127-128 °C

127-128 °C

127 - 128 °C

Physical DescriptionSolid
Collision Cross Section149.7 Ų [M+H]+ [CCS Type: TW; Method: calibrated with Waters Major Mix]

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Warning

H312 (56.8%): Harmful in contact with skin [Warning Acute toxicity, dermal]

P203, P261, P271, P280, P302+P352, P304+P340, P317, P318, P321, P362+P364, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 74 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Regulatory InformationTinidazole: Does not have an individual approval but may be used under an appropriate group standard
Other Safety InformationIMAP assessments - 1H-Imidazole, 1-[2-(ethylsulfonyl)ethyl]-2-methyl-5-nitro-: Environment tier I assessment
FDA Requirements · 1건

The Approved Drug Products with Therapeutic Equivalence Evaluations List identifies currently marketed prescription drug products, incl tinidazole, approved on the basis of safety and effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act.

Special ReportsManes G, Balzano A.; Tinidazole: From Protozoa to Helicobacter Pylori--The Past, Present and Future of a Nitroimidazole with Peculiarities; Expert Rev Anti Infect Ther 2 (5): 695-705 (2004)
Hazard Classes and CategoriesAcute Tox. 4 (56.8%)

안전 및 보호

Disposal Methods · 1건

SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational exposure or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal, aquatic, and plant life; and conformance with environmental and public health regulations.

화학 및 산업

약리 정보

ATC Code · 6건

J01XD02

P - Antiparasitic products, insecticides and repellents

J - Antiinfectives for systemic use

G - Genito urinary system and sex hormones

QG - Genito urinary system and sex hormones

QJ - Antiinfectives for systemic use

Protein BindingPlasma protein binding of tinidazole is 12%.
Pharmacodynamics · 1건

Tinidazole is a synthetic antiprotozoal agent. Tinidazole demonstrates activity both in vitro and in clinical infections against the following protozoa: <i>Trichomonas vaginalis</i>, <i>Giardia duodenalis</i> (also termed <i>G. lamblia</i>), and <i>Entamoeba histolytica</i>. Tinidazole does not appear to have activity against most strains of vaginal lactobacilli.

Mechanism of Action · 2건

Tinidazole is a prodrug and antiprotozoal agent. The nitro group of tinidazole is reduced in <i>Trichomonas</i> by a ferredoxin-mediated electron transport system. The free nitro radical generated as a result of this reduction is believed to be responsible for the antiprotozoal activity. It is suggested that the toxic free radicals covalently bind to DNA, causing DNA damage and leading to cell death. The mechanism by which tinidazole exhibits activity against <i>Giardia</i> and <i>Entamoeba</i> species is not known, though it is probably similar.

The nitro group of tinidazole is reduced by cell extracts of Trichomonas. As a result of this reduction a free nitro radical is generated which may be responsible for the antiprotozoal activity. The mechanism by which tinidazole exhibits activity against Giardia and Entamoeba species is not known.

Biological Half-Life · 2건

The elimination half-life is 13.2±1.4 hours and the plasma half-life is 12 to 14 hours.

Elimination: 13.2 (+ or - 1.4) hours. Plasma: approximately 12 to 14 hours.

Metabolism/Metabolites · 2건

Hepatic, mainly via CYP3A4. Tinidazole, like metronidazole, is significantly metabolized in humans prior to excretion. Tinidazole is partly metabolized by oxidation, hydroxylation and conjugation. Tinidazole is the major drug-related constituent in plasma after human treatment, along with a small amount of the 2-hydroxymethyl metabolite.

관련 반응

3건
반응 기록 만들기
HRID 125211 반응식
HRID 125211생성물로
HRID 681391 반응식
HRID 681391생성물로
HRID 971469 반응식
HRID 971469생성물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트

물리화학적 성질

녹는점
118 · 118-120C
끓는 점
528.4 · 528.4±30.0 °C(Predicted)
밀도
1.4338 · 1.4338 (rough estimate)
굴절률
1.632 · 1.6320 (estimate)
저장 조건
Sealed in dry,Room Temperature
용해도
물에 거의 녹지 않으며, 아세톤과 염화메틸렌에 녹고, 메탄올에는 거의 녹지 않습니다.
산도 계수 (pKa)
2.3 · 2.30±0.34(Predicted)
물리적 상태
Solid
색상
황백색에서 연한 노란색
Merck
14 · 14,9447
BRN
618182 · 618182
Henry's Law Constant
1.9 · 1.9×105 mol/(m3Pa) at 25℃, HSDB (2015)
안정성
안정적인. 강한 산화제와 호환되지 않습니다.
주요 응용
법의학 및 독성학의약품(소분자)
InChI
1S/C8H13N3O4S/c1-3-16(14,15)5-4-10-7(2)9-6-8(10)11(12)13/h6H,3-5H2,1-2H3
InChIKey
HJLSLZFTEKNLFI-UHFFFAOYSA-N
SMILES
CCS(=O)(=O)CCn1c(C)ncc1[N+]([O-])=O

화학적 성질

solid

독성 정보

Interactions · 5건

Cholestyramine may decrease oral bioavailability; separate dosing of cholestyramine and tinidazole is recommended.

Effects may be enhanced when these agents /coumarin anticoagulants/ are used concurrently with tinidazole resulting in prolongation of prothrombin time; dosage of oral anticoagulants may need to be adjusted during tinidazole therapy and up to 8 days after discontinuation.

It is recommended that these substances /ethyl alcohol, ethanol-containing preparations, propylene glycol/ not be used concurrently with tinidazole, or for 3 days following tinidazole therapy; abdominal cramps, nausea, vomiting, headache, or flushing may occur.

Concomitant administration /of intravenous phenytoin or intravenous fosphenytoin/ with tinidazole increases half life and decreases clearance of phenytoin.

For more Interactions (Complete) data for TINIDAZOLE (11 total), please visit the HSDB record page.

Hepatotoxicity · 1건

Tinidazole is typically given for a few days only, but serum enzyme elevations have been reported with its use, and serum enzyme elevations during therapy is listed as a possible adverse event in the product label. Tinidazole is also capable of causing anaphylactic and allergic reactions including urticaria, angioedema and bronchospasm, reactions which can be associated with minor serum enzyme elevations. Tinidazole, despite considerable use worldwide, has not been linked convincingly to instances of clinically apparent liver injury with jaundice.

Environmental Fate · 3건

TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 15(SRC), determined from a log Kow of -0.35(2) and a regression-derived equation(3), indicates that tinidazole is expected to have very high mobility in soil(SRC). The estimated pKa of tinidazole is 4.7 (sp2 hybridized imidazole nitrogen)(4), indicating that this compound will exist partially as a cation in the environment under acidic conditions and cations generally have lower mobility in soil than their neutral counterparts(5). Volatilization of tinidazole from moist soil surfaces is not expected to be an important fate process(SRC) because cations do not volatilize and based on an estimated Henry's Law constant of 5.2X10-11 atm-cu m/mole(SRC), calculated using a fragment constant estimation method(6). Tinidazole is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 2.7X10-7 mm Hg(SRC), determined from a fragment constant method(7). Biodegradation data were not available(SRC, 2005).

AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 15(SRC), determined from a log Kow of -0.35(2) and a regression-derived equation(3), indicates that tinidazole is not expected to adsorb to suspended solids and sediment(SRC). The estimated pKa of tinidazole is 4.7 (sp2 hybridized imidazole nitrogen)(3), indicating that this compound will exist partially as a cation in the environment under acidic conditions and cations generally adsorb more strongly to sediment than their neutral counterparts(4). Volatilization from water surfaces is not expected(5) because cations do not volatilize and based upon an estimated Henry's Law constant of 5.2X10-11 atm-cu m/mole(SRC), developed using a fragment constant estimation method(6). According to a classification scheme(7), an estimated BCF of <1(SRC), from the measured log Kow(2) and a regression-derived equation(8), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Biodegradation data were not available(SRC, 2005).

ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), tinidazole, which has an estimated vapor pressure of 2.7X10-7 mm Hg at 25 °C(SRC), determined from a fragment constant method(2), is expected to exist solely in the particulate phase in the ambient atmosphere. Particulate-phase tinidazole may be removed from the air by wet or dry deposition(SRC). Tinidazole does not contain chromophores that absorb at wavelengths >290 nm and therefore is not expected to be susceptible to direct photolysis by sunlight(SRC).

Milk ConcentrationsTinidazole is distributed into breast milk at concentrations similar to those in serum.
Soil Adsorption/Mobility · 1건

The Koc of tinidazole is estimated as 15(SRC), using a log Kow of -0.35(1) and a regression-derived equation(2). According to a classification scheme(3), this estimated Koc value suggests that tinidazole is expected to have very high mobility in soil. The estimated pKa of tinidazole is 4.7 (sp2 hybridized imidazole nitrogen)(4), indicating that this compound will partially exist in the cation form in the environment under acidic conditions and cations generally have lower mobility in soil than their neutral counterparts(5).

Artificial Pollution SourcesTinidazole's production and use as an antiprotozoal agent(1) may result in its release to the environment through various waste streams(SRC).
Drug Induced Liver Injury · 6건

Drug Induced Liver Injury Rank (DILIrank 2.0)

Tinidazole

vLess-DILI-concern

3

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Environmental Bioconcentration · 1건

An estimated BCF of <1 was calculated for tinidazole(SRC), using a log Kow of -0.35(1) and a regression-derived equation(2). According to a classification scheme(3), this BCF suggests the potential for bioconcentration in aquatic organisms is low(SRC).

Volatilization from Water/Soil · 1건

The Henry's Law constant for tinidazole is estimated as 5.2X10-11 atm-cu m/mole(SRC) using a fragment constant estimation method(1). The estimated pKa of tinidazole is 4.7 (sp2 hybridized imidazole nitrogen)(2), indicating that this compound will exist partially as a cation in the environment under acidic conditions. Based on this Henry's Law constant and the fact that cations do not volatilize, tinidazole is expected to be essentially nonvolatile from moist soil and water surfaces(3). Tinidazole is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 2.7X10-7 mm Hg(SRC), determined from a fragment constant method(4).

Non-Human Toxicity Excerpts · 5건

/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ Metronidazole, a chemically-related nitroimidazole, has been reported to be carcinogenic in mice and rats but not hamsters. In several studies metronidazole showed evidence of pulmonary, hepatic and lymphatic tumorigenesis in mice and mammary and hepatic tumors in female rats. Tinidazole carcinogenicity studies in rats, mice or hamsters have not been reported.

/LABORATORY ANIMALS: Developmental or Reproductive Toxicity/ Embryo-fetal developmental toxicity studies in pregnant mice indicated no embryo-fetal toxicity or malformations at the highest dose level of 2,500 mg/kg.

/LABORATORY ANIMALS: Developmental or Reproductive Toxicity/ Sixty-day fertility study done in male rats given doses (600 mg/kg/day) of tinidazole, resulting in reduced fertility and produced testicular histopathology. Spermatogenic effects resulted from dose levels of 300 and 600 mg/kg/day, while the no observed adverse effects dose level was 100 mg/kg/day. These effects are characteristic of agents in the 5-nitroimidazole class.

/LABORATORY ANIMALS: Developmental or Reproductive Toxicity/ In a study with pregnant rats a slightly higher incidence of fetal mortality was observed at a maternal dose of 500 mg/kg. No biologically relevant neonatal developmental effects were observed in rat neonates following maternal doses as high as 600 mg/kg.

/GENOTOXICITY/ Tinidazole was found to be mutagenic in the TA100, S. typhimurium testere strain both with and without the metabolic activation system and was not mutagenic in the TA98 strain. However mutagenicity results were mixed both positive and negative in the TA1535, 1537, and 1538 strains. Tinidazole was also positive in a tester strain of Klebsiella pneumonia and positive for in vivo genotoxicity in the mouse micronucleus assay. Tinidazole was negative for mutagenicity in a mammalian cell culture system with Chinese hamster lung V79 cells and negative for genotoxicity in the Chinese hamster ovary sister chromatid exchange assay.

Environmental Abiotic Degradation · 1건

Tinidazole is not expected to undergo hydrolysis in the environment due to the lack of functional groups that hydrolyze under environmental conditions(1). Tinidazole does not contain chromophores that absorb at wavelengths >290 nm and therefore is not expected to be susceptible to direct photolysis by sunlight(SRC).

Probable Routes of Human Exposure · 1건

Occupational exposure to tinidazole may occur through inhalation and dermal contact with this compound at workplaces where tinidazole is produced or used. Exposure to tinidazole among the general population may be limited to those administered this substance as a drug. (SRC)

규제 정보

FDA Requirements · 1건

The Approved Drug Products with Therapeutic Equivalence Evaluations List identifies currently marketed prescription drug products, incl tinidazole, approved on the basis of safety and effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act.

안전 데이터

wgk
3
rtecs
NI6255000
독성
LD50 in mice (mg/kg): >3600 orally; >2000 i.p. (Miller)
HS 번호
2933290000
risk_code
20/21/22-40
hazard_code
Xn
safety_code
26-36
기존화학 물질
KE-14058
Hazard Classifications
Acute Tox. 4 DermalAcute Tox. 4 InhalationCarc. 2Muta. 2
스토리지 클래스
11 - Combustible Solids
유해 물질 데이터
19387-91-8(Hazardous Substances Data)

Tinidazole, like metronidazole, is significantly metabolized in humans prior to excretion. Tinidazole is partly metabolized by oxidation, hydroxylation and conjugation. Tinidazole is the major drug-related constituent in plasma after human treatment, along with a small amount of the 2-hydroxymethyl metabolite. Tinidazole is biotransformed mainly by CYP3A4. In an in vitro metabolic drug interaction study, tinidazole concentrations of up to 75 ug/mL did not inhibit the enzyme activities of CYP1A2, CYP2B6, CYP2C9, CYP2D6, CYP2E1 and CYP3A4.

FDA Pharmacological Classification · 6건

033KF7V46H

TINIDAZOLE

Established Pharmacologic Class [EPC] - Nitroimidazole Antimicrobial

Chemical Structure [CS] - Nitroimidazoles

Tinidazole is a Nitroimidazole Antimicrobial.

TINIDAZOLE

MeSH Pharmacological Classification · 3건

Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases.

Agents used to treat trichomonas infections.

Substances that inhibit the growth or reproduction of BACTERIA.

Absorption, Distribution and Excretion · 6건

Rapidly and completely absorbed under fasting conditions. Administration with food results in a delay in Tmax of approximately 2 hours and a decline in Cmax of approximately 10% and an AUC of 901.6 ± 126.5 mcg hr/mL.

Tinidazole crosses the placental barrier and is secreted in breast milk. Tinidazole is excreted by the liver and the kidneys. Tinidazole is excreted in the urine mainly as unchanged drug (approximately 20-25% of the administered dose). Approximately 12% of the drug is excreted in the feces.

50 L

Tinidazole is distributed into virtually all tissues and body fluids. Tinidazole also crosses the blood-brain barrier, placental barrier and is distributed into breast milk. Volume of distribution (VolD): about 50 L.

Under fasted conditions tinidazole is rapidly and completely absorbed. Administration with food resulted in a delay in Tmax of approximately 2 hours and a decline in Cmax of approximately 10% and an AUC of 901.6 + or - 126.5 ug hr/mL.

Time to peak concentration: 1.6 (+ or - 0.7 hours)

Cellular LocationsCytoplasm

용도 및 제조

Uses · 3건

MEDICATION

Antitrichomonal Agents

Antiprotozoal and antibacterial activity

Methods of ManufacturingSynthesis: heating 2-methyl-5-nitroimidazole with 2-ethylsulfonylethyl-4-toluenesulfonate for 4 h
Formulations/PreparationsOral: Tablets, film-coated: 250 mg Tindamax (scored), (Presutti); 500 mg Tindamax (scored), (Presutti).
Use ClassificationPharmaceuticals -> Animal Drugs -> Approved in Taiwan

응용 분야

용도Antiprotozoal (Trichomonas, Giardia); antiamebic; antibacterial.

상·하류 제품 정보

상류 원료

파라-톨루엔설폰일 염화물2-(에틸술포닐)에탄올2-메틸-5-니트로이미다졸